BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34626053)

  • 1. Multi-miRNA panel of tumor-derived extracellular vesicles as promising diagnostic biomarkers of early-stage breast cancer.
    Kim MW; Park S; Lee H; Gwak H; Hyun KA; Kim JY; Jung HI; Il Kim S
    Cancer Sci; 2021 Dec; 112(12):5078-5087. PubMed ID: 34626053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients.
    Ozawa PMM; Vieira E; Lemos DS; Souza ILM; Zanata SM; Pankievicz VC; Tuleski TR; Souza EM; Wowk PF; Urban CA; Kuroda F; Lima RS; Almeida RC; Gradia DF; Cavalli IJ; Cavalli LR; Malheiros D; Ribeiro EMSF
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma extracellular vesicle‑packaged microRNAs as candidate diagnostic biomarkers for early‑stage breast cancer.
    Yan C; Hu J; Yang Y; Hu H; Zhou D; Ma M; Xu N
    Mol Med Rep; 2019 Nov; 20(5):3991-4002. PubMed ID: 31545424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
    Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.
    Bao S; Hu T; Liu J; Su J; Sun J; Ming Y; Li J; Wu N; Chen H; Zhou M
    J Nanobiotechnology; 2021 Jan; 19(1):22. PubMed ID: 33436002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma.
    Yao B; Qu S; Hu R; Gao W; Jin S; Liu M; Zhao Q
    FEBS Open Bio; 2019 Dec; 9(12):2149-2158. PubMed ID: 31677346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
    Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
    Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Schrauder MG; Strick R; Schulz-Wendtland R; Strissel PL; Kahmann L; Loehberg CR; Lux MP; Jud SM; Hartmann A; Hein A; Bayer CM; Bani MR; Richter S; Adamietz BR; Wenkel E; Rauh C; Beckmann MW; Fasching PA
    PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
    Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
    BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer.
    Roman-Canal B; Tarragona J; Moiola CP; Gatius S; Bonnin S; Ruiz-Miró M; Sierra JE; Rufas M; González E; Porcel JM; Gil-Moreno A; Falcón-Pérez JM; Ponomarenko J; Matias-Guiu X; Colas E
    J Transl Med; 2019 Jun; 17(1):208. PubMed ID: 31221189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
    Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
    Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB
    BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.
    Kim SS; Baek GO; Ahn HR; Sung S; Seo CW; Cho HJ; Nam SW; Cheong JY; Eun JW
    Mol Oncol; 2020 Oct; 14(10):2646-2659. PubMed ID: 32525601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors.
    Strømme O; Heck KA; Brede G; Lindholm HT; Otterlei M; Arum CJ
    Curr Issues Mol Biol; 2021 Jun; 43(1):286-300. PubMed ID: 34199766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer.
    Giordano C; Accattatis FM; Gelsomino L; Del Console P; Győrffy B; Giuliano M; Veneziani BM; Arpino G; De Angelis C; De Placido P; Pietroluongo E; Zinno F; Bonofiglio D; Andò S; Barone I; Catalano S
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of micrornas in molecular genetic breast cancer subtypes.
    Kolesnikov NN; Veryaskina YA; Titov SE; Rodionov VV; Gening TP; Abakumova TV; Kometova VV; Torosyan MK; Zhimulev IF
    Cancer Treat Res Commun; 2019; 20():100026. PubMed ID: 31255253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma.
    Gao S; Guo W; Liu T; Liang N; Ma Q; Gao Y; Tan F; Xue Q; He J
    Cancer Sci; 2022 Feb; 113(2):648-659. PubMed ID: 34837453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A miRNA signature in endothelial cell-derived extracellular vesicles in tumor-bearing mice.
    McCann JV; Liu A; Musante L; Erdbrügger U; Lannigan J; Dudley AC
    Sci Rep; 2019 Nov; 9(1):16743. PubMed ID: 31727903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.